Liver disease is on the rise, and is now the fifth largest killer in the UK. Currently, 50% of new diagnoses of liver cirrhosis occur after emergency admission to hospital.
Neil is a Clinical Associate Professor in Hepatology, University of Nottingham and Consultant Hepatologist, at Nottingham University Hospitals and his innovation aims to deal with this issue by identifying patients at risk at an earlier stage.
Neil has co-developed a diagnostic pathway to detect significant but asymptomatic chronic liver disease at the critical stage at which it can either progress or reverse. The pathway combines both the identification of patients at risk of chronic liver diseases and the use of proven diagnostic tests to detect and treat the risk. It aims to provide a seamless pathway between primary and secondary care.
Liver disease diagnostic pathway in the NIA
The NIA has helped Neil test the diagnosis pathway in Nottingham and Leicester and hopes to expand it across the rest of the East Midlands and eventually nationally. The pilot area covers a population of over 25,000 patients and is supported by the East Midlands Academic Health Science Network (AHSN) for the next two years
“Taking part in this project changed my life and continues to do so. It enabled me to take to control of my life once again after a period of alcohol dependency. The whole process has had a positive effect on myself and my family. Find it hard to say how lucky I feel to have taken part in the project. A real game changer for me!”
“The early detection of liver disease represents an important aspect in reversing premature and unnecessary deaths from liver disease. With support from partnership organisations including CCGs, Public Health East Midlands and the Academic Health Science Network we are trying to change pathways of care and make fundamental changes to how we manage liver disease in the UK.”